News
From Period Tracking to Fertility: What Makes Women Use Health Apps
In the last decade, women’s health technology has come a long way. It began as rudimentary period and ovulation trackers, evolving into a highly developed fertility-focused platform with all sorts of services — cycle predictions to conception assistance.
Then what is causing this growth, and more importantly, what is it that makes women actually use these apps? In this article, I will analyze the key factors that influence the adoption and sustained engagement with women’s health platforms, drawing on experience from healthcare software development services to highlight best practices. Features to include in the application are drawn from usage statistics, user interviews, industry reports, app feature analysis, and so on. Core focus areas include:
- Evolution of femtech from period trackers to fertility tools
- Key drivers and needs spurring femtech adoption
- Factors influencing continued and increased usage
- Role of accuracy, privacy, access to experts, etc., in user retention
- How consumer needs are shifting from tracking to planning, prediction and intervention
- Market outlook, opportunities and challenges ahead
The Femtech Growth Trajectory
Femtech grew at a phenomenal rate from $250M in 2015 to around $39.29 billion in 2024. Women’s health technology has been going mainstream since the launch of the popular fertility app Glow in 2013, unicorn startups like Modern Fertility raising more than $160 million in funding, and everything in between.
But how did we get here? Let’s do a quick retrospective first.
The Beginnings – Period Tracking
For most female health apps on the market today, the journey began with period tracking. When Glow first debuted nearly a decade ago, it tapped into an unmet need for women to easily record and analyze their menstrual cycles using their smartphones.
Soon, similar apps such as Clue, Flo, Eve and so on started catching on, allowing women to log not only periods but also moods, symptoms, sexual activity and so on. However, the aggregation of this rich longitudinal data provided groundbreaking views of individual cycles and patterns, underscoring the importance of thoughtful healthtech UX in making that data both accessible and actionable.
It was obvious why – Flo had over 15 million downloads by 2016, and Clue had gotten almost 5 million users. The success of tracking-based apps was the beginning of the shape of women’s health tech that was yet to come.
Pregnancy Planning and Ovulation Tracking
Period trackers showed women their cycles, but the next steps were still left to be determined. The obvious next step was to develop these apps into forward-thinking planning tools designed to achieve things like preventing pregnancy or maximizing the chances of conception.
Since Ovia is a modern fertility app that not just gives a forecast of when you will be ovulating, period, but also provides personalized advice and analysis for effective family planning or getting pregnant faster. This allows users to log basal body temperature, cervical fluid consistency, intercourse details and more for more accuracy.
Many trackers now integrate with wearables and connected devices for passive data collection rather than relying solely on manual logging. They leverage predictive analytics and machine learning on the aggregate data to refine predictions and insights further.
The Market Expands – Fertility, Menopause and More
From ovulation and conception tools, femtech startups have diversified into adjacent women’s health segments:
- Fertility testing: Modern Fertility, EverlyWell, Natalist
- Menopause support: Genneve, Elektra Health
- Pelvic and sexual health: Minna Life, Elvie
- Pregnancy care: Peanut, Expectful
- General women’s wellness: Tia, Willow
Instead of just tracking cycles, these companies provide proactive health screenings, community support, telehealth access, and personalized care plans around issues like family planning, sexual wellness, pregnancy, menopause, and so on.
While some apps have retained an informational focus, newer entrants promise a combination of community support, telehealth access and even prescription delivery at home. The scope spans reproductive health, pregnancy, menopause and overall wellness.
So what exactly is propelling this femtech boom and persuading women to use these health apps? Let’s analyze some key drivers and consumer needs.
What’s Driving Femtech Adoption Among Women
The runaway success of femtech apps points to some clear unmet needs among women that this technology is serving. What core user requirements are these platforms addressing?
Need for Personalized Insights
Every woman’s cycle and reproductive health needs are unique. While medical guidelines exist, they provide blanket recommendations instead of tailored insights. Femtech apps fill this gap.
Personalized predictions and analysis come about through sophisticated algorithms that crunch individual tracking data against crowdsourced benchmarks. It allows women to decode their own patterns and preferences rather than depend on made-up assumptions.
The Desire to Be Proactive
Traditionally, women had to be reactive on reproductive health issues, whether by means of social taboos or medical norms. Using fertility apps enables them to take charge.
Instead of passively waiting for periods, pregnancies or menopause to happen unexpectedly, femtech apps allow women to foresee them and prepare mentally as well as physically.
Modern Fertility found that most of their users joined to understand their fertility proactively instead of waiting until they started trying or faced issues. The ability to drive their own health trajectories draws women to these platforms.
Need for Community Support
Reproductive experiences like pregnancy and menopause can feel emotionally isolating. Women often have nowhere to openly discuss concerns and challenges.
For instance, femtech apps that have community forums, such as Peanut and Gennev, offer solidarity and support from other women who are going through the same experience. A report by L.E.K. Consulting highlights that unmet needs in women’s health often include emotional support, particularly during pregnancy, postpartum, and reproductive health journeys. The apps turn out to serve a dual purpose — tracking health data and also serving as mental health assistance when required.
Convenience and Accessibility
Perhaps the most straightforward driver is that femtech apps offer low effort and high convenience. Instead of scheduling doctors’ visits, waiting for tests or taking time off work, essential health data, advice and interventions are available 24/7 on women’s phones.
Easy connectivity with wearables for automated data collection also minimizes the logging needed. Their usage often increases in tandem with the level of effortless tracking enabled.
The convenience quotient goes a notch higher with the ability to order testing kits, get prescriptions, and access experts online from home, apart from just monitoring cycles. Managing health is really lower than ever.
What keeps people engaged with these apps long term, once the appeal to women is made?
Factors Driving Sustained Usage of Femtech Apps
Though downloads are easy to attain, not all users are actively using health apps. Building trust is a key to retaining users. What exactly is it that makes women users keep coming back to femtech platforms from week to week?
Accuracy of Tracking and Predictions
“Garbage in, garbage out” applies strongly to data-driven femtech apps. Erroneous period or fertility forecasts will frustrate women instead of helping them. Builders have to continually refine accuracy by sourcing more data points and improving algorithms.
Apps explicitly show prediction precision to retain user trust. Flo displays monthly accuracy scores for period tracking. Proven test results and doctor reviews also reinforce reliability for fertility testing apps.
User feedback is open on the best platforms, which then use it to amend cycle analysis anomalies. To sustain usage, you have to show progress in precision through transparency.
Relevance of Recommendations
True generic wellness advice doesn’t pull you towards engaging. Femtech apps have to give specific suggestions for each woman’s reproductive profile and health objectives.
Period trackers can push appropriately timed exercise regimens, nutrition plans, self-care prompts, etc., based on where users are in their cycle. Apps also educate women on high fertility days, early pregnancy precautions, menopause management, and more based on phase-specific needs.
Personalization requires synthesizing their tracked data, stated goals and contextual information like age, weight, health conditions, etc. Actionable and relevant recommendations specific to the user keep women checking back in.
Holistic Support Across Needs
Across life stages, women’s needs change from contraception to conception aid to menopause support. This aligns with this changing requirement, which encourages prolonged usage instead of single-purpose apps.
For instance, Tia started as a period/ovulation tracker but now also offers gynecological care, sexual health, pregnancy support, postpartum care and menopause services. Ovia’s suite of apps covers different stages like pregnancy, parenting and fertility.
Femtech apps positioned as long-term partners in women’s health win more loyalty compared to point solutions.
Access to Health Experts
While period and ovulation trackers are a great foundation for data, women usually need professional help to understand the implications.
Direct access to gynecologists, reproductive endocrinologists, pelvic floor therapists, mental health professionals, etc., through chat/call features builds credibility for femtech apps. It also fosters emotional reassurance when dealing with sensitive concerns.
Modern Fertility provides free 30-minute consults with fertility nurses to users. Others, like Minna Life and Genneve, enable in-app physician appointments. The convenience of expert medical advice, without appointments or clinic visits, keeps women returning.
Sense of Security and Privacy
In particular, privacy and data security are key to user comfort when dealing with intimate information such as cycles, sexual activity, contraception, pregnancy, etc.
Even the most useful apps risk being abandoned if they are hacked, data is leaked, or shared with concerns. Reassuring users proactively and explaining safety precautions in place results in more peace of mind.
Femtech apps include encryption methods, access controls and transparency on how data is used, and even include the ability to delete past entries irretrievably. Maintaining people’s sensitive medical history securely earns their ongoing reliance.
The Path Ahead for Femtech
Although women’s health technology has achieved widespread success, its use cases and market potential remain largely unexplored. However, some pertinent opportunities and challenges exist ahead.
Evolution from Tracking to Treatment
The end goal for femtech cannot be just monitoring and predicting reproductive health. True value addition will require helping women intervene in and improve their outcomes proactively.
This is the path forward: Modern Fertility’s entrance into personalized fertility treatment plans based on assessments. Apps will go beyond tracking to include prescription drugs, hormonal therapies delivered at home, at-home insemination tools, remote menopause counseling, and many more.
Preventive and corrective health will be the next frontier.
Overcoming Drop-Offs
The biggest threat to femtech’s future is abandonment after initial interest. Period-tracking app users stop engaging after three months at a rate of 72 percent. Principal drop-off drivers include privacy concerns, burden overhead, poor predictions, no actionability, and no support when vulnerable.
For the extended life, this will drive continued usage and therefore require ongoing value through better data integrations, personalized engagement features, and access to care. Alignment of early attrition risks and correcting them will be vital.
Operationalizing Robust Research
Femtech apps have access to very rich fertility health data at scale from millions of women around the world. The data capital contained in this has the potential to accelerate new reproductive research and insights faster than ever.
However, we must systematically operationalize the research potential, utilizing in-house experts and forming partnerships with university labs, hospitals, and biopharma companies. Here, data security and commercialization opportunities are both needed.
Responsible forging of robust medical research partnerships will open the doors to biomarkers of disease and early interventions, and much more.
Aligning with Evolving Market Needs
Women’s health needs are diverse and ever-evolving. The femtech market has expanded across subcategories like pregnancy tech, menopause tech and more. Continued fragmentation is imminent as startups spot newer micro opportunities.
But if they confuse users, this also runs the risk of confusing users. Consequently, apps must be specialized and simultaneously integrated across categories in accordance with what the user wants. Even while expanding the scope, the fundamental promise to women must be fulfilled.
Conclusion
Overall, femtech has been adopted because it addresses women’s need for personalized and proactive health insights. Retention is proving critical as convenience, community and access to care during vulnerable times.
However, data no longer needs to be overly passively tracked. We need a future, and enabling interventions by intelligent predictions, prescriptions, and expert guidance is necessary. Another bucket of potential will be unlocked by data security and partnerships.
As femtech builders expand their scope, they must remain in alignment with the core requirements of accuracy, convenience, and access to care for women. The promise of data-driven women’s health is only going to be delivered against these pillars.
The beginning of transforming medical outcomes by putting control directly in women’s hands. It is an exciting time for the consumers and creators of femtech solutions.
Menopause
Menopause specialist Haver joins Midi Health
Menopause specialist Dr Mary Claire Haver has been appointed as the first chief agewell officer at virtual care clinic Midi Health.
In the role, Dr Haver will work with Midi’s clinical team to develop the AgeWell platform, described as a proactive health model that integrates perimenopause and menopausal care with metabolic health, bone density, brain health and cardiovascular risk assessment.
The platform aims to provide preventative care targeting what the company describes as the primary drivers of female mortality and disability: heart disease, bone loss and cognitive decline.
Joanna Strober, chief executive and co-founder of Midi Health, said: “Longevity care has historically ignored women’s biology, especially during the critical windows of midlife and menopause.
“At Midi Health, we are committed to extending healthspan, not just lifespan, and making that care accessible to millions of women as a core pillar of their health.
“By collaborating with Dr Haver, we are ensuring women continue to have access to care designed for their bodies, their hormones, and their real lives.”
Dr Haver is board-certified in obstetrics and gynaecology, a Menopause Society certified practitioner, a certified culinary medicine specialist and an adjunct associate professor of obstetrics and gynaecology at The University of Texas Medical Branch.
After a career in academic medicine, Dr Haver founded The Pause Life, described as a science and education-based resource for women navigating perimenopause and the menopause transition.
Through her books, unPaused podcast and digital platform, she has provided education on midlife health.
Dr Mary Claire Haver said: “I have spent my career advocating for women to receive the science-backed, no-nonsense guidance they deserve.
“I chose to partner with Midi Health because they are the only platform with the scale and medical rigour to deliver the kind of care women deserve, regardless of their zip codes.
“Together, we are setting a new standard for proactive, preventative care that meaningfully extends both lifespan and healthspan for women.”
Entrepreneur
Kate Ryder headlines Women’s Health Week USA 2026 as full agenda goes live
Women’s Health Week USA 2026 has unveiled its first populated agenda, anchored by an opening keynote from Kate Ryder, Founder and CEO of Maven Clinic, and featuring a cross-sector lineup shaping the next phase of scale in women’s health.
You can view the full agenda here.
Taking place May 13–14, 2026, at the New York Academy of Medicine, Women’s Health Week USA brings together the full women’s health ecosystem to focus on one central question: what does it take to move women’s health from innovation to institutional scale?
Kate Ryder will open Day 1 with a keynote drawing on her experience building Maven Clinic into the world’s largest virtual clinic for women’s and family health.
Under her leadership, Maven has partnered with employers and health plans to deliver care across fertility, maternity, postpartum, paediatrics, and menopause at scale.
Her perspective sets the tone for a program centered on commercialisation, partnership, and sustainable growth.
Beyond the opening keynote, the newly released agenda reflects the sector’s growing maturity.
Across two days, the program features 70+ speakers, with representation from leading organizations including the FDA, Planned Parenthood, CVS Health Ventures, Samsung Next, NIH, WHO, and Maven Clinic.
Sessions span investment and deal flow, clinical innovation, regulation, data and technology, and market expansion, alongside dedicated pitch sessions and curated 1:1 matchmaking designed to turn insight into action.
The agenda has been built to facilitate meaningful connections across the ecosystem, with partnerships positioned as the primary driver of scale.
As women’s health continues to attract institutional capital and global attention, Women’s Health Week USA 2026 offers a clear snapshot of where the market is heading, and who is shaping it.
The full agenda is now live, with additional speakers and partners to be announced in the coming months.
View the full programme here.
Fertility
Most NHS regions in England limit IVF to single cycle, research finds
Nearly 70 per cent of NHS regions in England fund only one IVF cycle for women under 40, breaking national guidelines, new research has found.
Twenty-nine of the 42 integrated care boards, which control local NHS budgets, now offer only one round of treatment, after four reduced access in the past year.
National Institute for Health and Care Excellence (Nice) guidelines recommend three full cycles for women under 40 who have been unable to conceive for two years.
Only two of England’s 42 integrated care boards have policies consistent with these guidelines, which they are not legally obliged to follow.
The research was conducted by the Progress Educational Trust, a fertility charity.
Sarah Norcross, the director of PET, said the impact was “devastating” for couples struggling with infertility.
She said: “Infertility is already incredibly stressful for people, and it puts them under even more pressure, because there is so much riding on whether that one NHS-funded cycle is going to work.
“And for some people, that will be their only chance, because private fertility treatment is so expensive.”
The data showed regional variations, with the whole of the north-west offering just one cycle.
“It’s a postcode lottery, and we’re seeing a race to the bottom,” said Norcross.
Of the 29 integrated care boards that offer a single cycle, 19 provide only a partial cycle, where not all viable embryos created are transferred.
There was just one recent example of improved services, from NHS South East London, which in July 2024 went from one partial to two full cycles.
The NHS estimates that about one in seven couples may have difficulty achieving a pregnancy. One cycle of IVF can cost from £5,000 at a private clinic.
Fertility rates in England and Wales have fallen since 2010 to 1.41 children per woman in 2024, the lowest on record and below the replacement level of 2.1 at which a population is stable without immigration.
Health minister Karin Smyth said in a written parliamentary answer last month that it was “unacceptable” that access to NHS-funded fertility services varied across the country.
Revised Nice fertility guidelines are due this spring, but Norcross said changing them seemed pointless.
She said: “Fertility treatment has always been a Cinderella service. It’s always been the one they’ve chosen to cut or to ignore.
“Nice has recommended three full NHS-funded cycles, for women under 40, for more than 20 years. This has never been implemented across England, unlike in Scotland.”
Norcross advocated centralised commissioning and replicating Scotland’s approach, which included financial modelling and a phased implementation starting with two cycles to avoid long waits, moving up to three once capacity was achieved.
“It is a tried and tested plan that England could follow,” Norcross added.
A Department of Health and Social Care spokesperson said: “We recognise access to fertility treatment varies across the country and we are working with the NHS to improve consistency.
“Nice provides clear clinical guidelines, and we expect integrated care boards to commission treatment in line with these.
“Updated Nice fertility guidelines are expected this spring and we will continue to support NHS England to make sure the guidance is fully considered in local commissioning decisions.”
An NHS England spokesperson said: “These clinical services are commissioned by integrated care boards for their area based on the needs of the local population and prioritisation of resources available.
“All ICBs have a responsibility to ensure services are provided fairly and are accessible by different population groups.”
-
Features4 weeks agoWomen’s health enters a new era – the trends shaping femtech in 2026
-
Fertility4 weeks agoDesigner perfumes recalled over banned chemical posing fertility risk
-
Features4 weeks agoBest menopause apps and products for 2026
-
Insight2 weeks agoParents sue IVF clinic after delivering someone else’s baby
-
Insight3 weeks agoWomen’s health could unlock US$100bn by 2030
-
Wellness4 weeks agoHigher maternal blood pressure increases risk of pregnancy complications, study finds
-
Entrepreneur4 weeks agoXella Health closes US$3.7 million in pre-seed financing
-
Insight3 weeks agoChina’s birth rate hits record low despite government fertility efforts






